Grupo de Medicina Xenómica (USC), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
Hereditary Cancer Program, Catalan Institute of Oncology, Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Barcelona, Spain.
Sci Rep. 2021 May 27;11(1):11135. doi: 10.1038/s41598-021-90590-z.
Colorectal cancer (CRC) is a complex disease that can be caused by a spectrum of genetic variants ranging from low to high penetrance changes, that interact with the environment to determine which individuals will develop the disease. In this study, we sequenced 20 early-onset CRC patients to discover novel genetic variants that could be linked to the prompt disease development. Eight genes, CHAD, CHD1L, ERCC6, IGTB7, PTPN13, SPATA20, TDG and TGS1, were selected and re-sequenced in a further 304 early onset CRC patients to search for rare, high-impact variants. Although we found a recurring truncating variant in the TDG gene shared by two independent patients, the results obtained did not help consolidate any of the candidates as promising CRC predisposing genes. However, we found that potential risk alleles in our extended list of candidate variants have a tendency to appear at higher numbers in younger cases. This supports the idea that CRC onset may be oligogenic in nature and may show molecular heterogeneity. Further, larger and robust studies are thus needed to unravel the genetics behind early-onset CRC development, coupled with novel functional analyses and omic approaches that may offer complementary insight.
结直肠癌(CRC)是一种复杂的疾病,可能由从低到高外显率变化的一系列遗传变异引起,这些变异与环境相互作用,决定哪些个体将患上这种疾病。在这项研究中,我们对 20 名早发性 CRC 患者进行了测序,以发现可能与疾病快速发展有关的新的遗传变异。选择了 CHAD、CHD1L、ERCC6、IGTB7、PTPN13、SPATA20、TDG 和 TGS1 这 8 个基因,并在另外 304 名早发性 CRC 患者中重新进行了测序,以寻找罕见的、高影响的变异。尽管我们在两个独立的患者中发现了 TDG 基因中重复出现的截断变异,但结果并没有帮助我们将任何候选基因确定为有前途的 CRC 易感性基因。然而,我们发现,我们候选变异列表中的潜在风险等位基因在年轻病例中出现的频率更高。这支持了 CRC 发病可能具有寡基因性质并可能表现出分子异质性的观点。因此,需要进行更大规模和更稳健的研究来揭示早发性 CRC 发展背后的遗传学,并结合新的功能分析和组学方法,这可能提供互补的见解。